CYP21A2 and congenital adrenal hyperplasia: Then, to confirm clinical suspicion of the CAH disease, we performed a reverse dot blot (Figure 2) and Multiplex Ligation-dependent Probe Amplification (MLPA) (Figure 3) on CYP21A2 gene of the patient and parental DNA.